icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Barcelona, Spain
13-17 April 2016
Back grey_arrow_rt.gif
 
 
 
Daclatasvir and Sofosbuvir Therapy for Patients with Decompensated Cirrhosis or Post-Liver Transplant HCV Recurrence and Advanced Fibrosis or Cirrhosis: United States Multicentre Treatment Protocol
 
 
  Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
 
Brown Jr RS,1 Fried MW,2 Reddy KR,3 Soldevila-Pico C,4 Khemichian S,5 Darling J,2 Napoli AA,6 Anduze-Faris B,6 Kwo P7
1Weill Cornell Medical College, Center for Liver Disease, New York, NY, USA; 2University of North Carolina, Chapel Hill, NC, USA; 3Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA; 4Department of Medicine, University of Florida, Gainesville, FL, USA; 5Keck School of Medicine, University of Southern California, Los Angeles, CA, USA;
6Bristol-Myers Squibb, Plainsboro, NJ, USA; 7Indiana University, Indianapolis, IN, USA

EASL1

EASL2

EASL3

EASL4

EASL5

EASL6

EASL7

EASL8

EASL9

EASL10

EASL11

EASL12